BALAXI PHARMACEUTICALS LIMITED

BALAXI

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202616

    Quarter₹ croreYoY
    Jun 202419-24.0%
    Sept 202421+27.8%
    Dec 202411-12.1%
    Mar 202510-39.3%
    Jun 202517-12.2%
    Sept 202519-8.7%
    Dec 202525+120.4%
    Mar 202620+109.8%
    Jun 202616-6.7%
  • ₹ crore

    Jun 20260.92

    Quarter₹ crore
    Jun 20240.85
    Sept 20241
    Dec 20243
    Mar 20250.32
    Jun 20250.46
    Sept 20254
    Dec 20252
    Mar 20263
    Jun 20260.92
  • ₹ crore

    Jun 202616

    Quarter₹ crore
    Jun 202420
    Sept 202422
    Dec 202414
    Mar 202510
    Jun 202517
    Sept 202524
    Dec 202526
    Mar 202624
    Jun 202616
  • Cost structure
  • ₹ crore

    Jun 20262

    Quarter₹ crore
    Jun 20241
    Sept 20241
    Dec 20241
    Mar 20251
    Jun 20251
    Sept 20251
    Dec 20251
    Mar 20262
    Jun 20262
  • ₹ crore

    Jun 202618

    Quarter₹ crore
    Jun 202418
    Sept 202420
    Dec 202412
    Mar 202511
    Jun 202517
    Sept 202519
    Dec 202524
    Mar 202623
    Jun 202618
  • Exceptional items and tax
  • ₹ crore

    Jun 2026-1

    Quarter₹ crore
    Jun 20242
    Sept 20242
    Dec 20242
    Mar 2025-1
    Jun 20250.26
    Sept 20254
    Dec 20252
    Mar 20260.41
    Jun 2026-1
  • ₹ crore

    Jun 20260.14

    Quarter₹ crore
    Jun 20240.51
    Sept 20240.54
    Dec 20240.59
    Mar 20250.04
    Jun 20250.06
    Sept 20250.98
    Dec 20250.59
    Mar 20260.26
    Jun 20260.14
  • Profit
  • ₹ crore

    Jun 2026-1

    Quarter₹ croreYoY
    Jun 20241-46.1%
    Sept 20242+40.5%
    Dec 20242+257.1%
    Mar 2025-1-104.9%*
    Jun 20250.19-85.8%
    Sept 20253+96.4%
    Dec 20252-12.2%
    Mar 20260.16+113.4%*
    Jun 2026-1-743.0%
  • Per share
  • ₹ per share

    Jun 2026-0.23

    Quarter₹ per share
    Jun 20240.25
    Sept 20240.30
    Dec 20240.32
    Mar 2025-0.21
    Jun 20250.04
    Sept 20250.59
    Dec 20250.28
    Mar 20260.03
    Jun 2026-0.23
  • Leverage
  • Debt to equity

    times

    Jun 20240.00x

    Quartertimes
    Jun 20240.00x
    Sept 2024—
    Dec 2024—
    Mar 2025—
    Jun 2025—
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
192111101719252016
Revenue YoY-24.0%+27.8%-12.1%-39.3%-12.2%-8.7%+120.4%+109.8%-6.7%
0.85130.320.464230.92
202214101724262416
Cost structure
111111122
182012111719242318
Exceptional items and tax
222-10.26420.41-1
0.510.540.590.040.060.980.590.260.14
Profit
122-10.19320.16-1
Net profit YoY-46.1%+40.5%+257.1%-104.9%*-85.8%+96.4%-12.2%+113.4%*-743.0%
Per share
0.250.300.32-0.210.040.590.280.03-0.23
Leverage
Debt to equity0.00x————————

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.